| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/08/2011 | US20110217378 Immobilization of bioactive molecules within a polymeric substrate |
| 09/08/2011 | US20110217376 Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same |
| 09/08/2011 | US20110217375 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
| 09/08/2011 | US20110217370 Substances for promoting healthy joint function comprising glucosamine sulfate, omega-3 polyunsaturated fatty acids or derivatives thereof, and undenatured type ii collagen |
| 09/08/2011 | US20110217363 Two-step targeted tumor therapy with prodrug encapsulated in nanocarrier |
| 09/08/2011 | US20110217362 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
| 09/08/2011 | US20110217356 Controlled delivery system |
| 09/08/2011 | US20110217354 Implants for administering substances and methods of producing implants |
| 09/08/2011 | US20110217349 System and method for supporting a biological chip device |
| 09/08/2011 | US20110217340 nanodisperse compositions |
| 09/08/2011 | US20110217337 Bioactive agent for bone tissue engineering |
| 09/08/2011 | US20110217332 Chimpanzee Adenovirus Vaccine Carriers |
| 09/08/2011 | US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
| 09/08/2011 | US20110217324 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/08/2011 | US20110217315 Methods and compositions for risk prediction, diagnosis, prognosis, and treatment of pulmonary disorders |
| 09/08/2011 | US20110217314 Methods and Compositions for Modulating Apoptosis |
| 09/08/2011 | US20110217313 Treatment of orthopedic conditions |
| 09/08/2011 | US20110217310 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology |
| 09/08/2011 | US20110217301 Methods for treating or screening for compounds for the treatment of sepsis |
| 09/08/2011 | US20110217300 Quinazolinone Compounds and Methods of Use Thereof |
| 09/08/2011 | US20110217295 Treatment of lupus arthritis using laquinimod |
| 09/08/2011 | US20110217290 Treatment and/or prevention of peanut induced anaphylaxis |
| 09/08/2011 | US20110217288 Involvement of Androgen/Androgen Receptor Pathway in Fabry Disease |
| 09/08/2011 | US20110217287 Therapeutic composition comprising a botulinum neurotoxin |
| 09/08/2011 | US20110217286 Stabilized anthocyanin compositions |
| 09/08/2011 | US20110217285 Keratin biomaterials for treatment of ischemia |
| 09/08/2011 | US20110217284 Factor IX Variants with Clotting Activity in Absence of Their Cofactor and Their Use for Treating Bleeding Disorders |
| 09/08/2011 | US20110217283 Stable galenic freeze-dried pharmaceutical preparation of recombinant carbohydrate-binding polypeptides |
| 09/08/2011 | US20110217282 Novel Toxin-Antitoxin System |
| 09/08/2011 | US20110217281 Methods for diagnosis and prognosis of cancer |
| 09/08/2011 | US20110217280 Methods for treating neuropsychiatric conditions |
| 09/08/2011 | US20110217279 Use of human biliverdin reductase and fragments thereof for the treatment of protein kinase c-delta and erk related conditions |
| 09/08/2011 | US20110217277 Drug or dermatological composition containing an avocado peptide extract for treating and preventing pruritus |
| 09/08/2011 | US20110217265 Screening for Inhibitors of HCV Amphipathic Helix (AH) Function |
| 09/08/2011 | US20110217264 Methods and compositions for delivery of exogenous factors to nervious system sites |
| 09/08/2011 | US20110217263 Expansion of haemopoietic precursors |
| 09/08/2011 | US20110217262 Treatment of Ocular Surface Disorders by Increasing Conjunctival Vascular Permeability |
| 09/08/2011 | US20110217261 Combination pharmaceutical agents as inhibitors of hcv replication |
| 09/08/2011 | US20110217260 Method of enhancing eyelash and eye brow hair growth |
| 09/08/2011 | US20110217259 IL-16 as a target for diagnosis and therapy of hematological malignancies and solid tumors |
| 09/08/2011 | US20110217258 Combined Use of Bendamustine, Doxorubicin and Bortezomib for the Treatment of Multiple Myeloma |
| 09/08/2011 | US20110217249 Compositions and Methods for the Treatment of Skin Diseases and Disorders Using Antimicrobial Peptide Sequestering Compounds |
| 09/08/2011 | US20110217235 Alpha 1-3 n-galactosyltransferase with altered donor specificities |
| 09/08/2011 | US20110217233 Modulation of intracellular signaling |
| 09/08/2011 | US20110217232 Method for Determination of the Responsiveness of an Individual to Misletoe Lectin |
| 09/08/2011 | DE102010010288A1 Medicament, useful to prevent or treat e.g. ulcerative colitis, comprises polypeptide sequences of cysteine-rich protein 61 (CCN1) and/or cyclic arginine-glycine-aspartic acid peptide, or nucleic acid encoding polypeptide sequence of CCN1 |
| 09/07/2011 | EP2363503A1 Modulation of HIF1A and HIF2A expression |
| 09/07/2011 | EP2363488A1 Postweaning multisystemic wasting syndrome virus from pigs |
| 09/07/2011 | EP2363487A2 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 09/07/2011 | EP2363483A2 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
| 09/07/2011 | EP2363480A2 Modulation of glucocorticoid receptor expression |
| 09/07/2011 | EP2363479A1 Oligoribonucucleotide for inhibiting the expression of a predefined gene |
| 09/07/2011 | EP2363478A1 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 09/07/2011 | EP2363413A1 Methods and compositions for the inhibition of modulation of T cell costimulatory pathway by a pathogenic agent |
| 09/07/2011 | EP2363411A1 GAG binding proteins |
| 09/07/2011 | EP2363406A2 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
| 09/07/2011 | EP2363405A1 Anti-infarction molecules |
| 09/07/2011 | EP2363404A2 PSMA antibodies |
| 09/07/2011 | EP2363152A1 Cardiac arrhythmia treatment methods |
| 09/07/2011 | EP2363142A1 Elastase for opening obstructed biological conduits |
| 09/07/2011 | EP2363141A1 Compsition comprising two oligonucleotides linked directly at their 3'ends wherein at leat one oligonucleotide has an accessible 5'end and the compound further comprising IL-2 used for synergistically stimulating an immune response in a patient. |
| 09/07/2011 | EP2363140A1 Antisecretory protein for use in the treatment of compartiment syndrome |
| 09/07/2011 | EP2363139A1 Method to increase class I presentation of exogenous antigens by human dendritic cells |
| 09/07/2011 | EP2363138A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring periodontal diseases |
| 09/07/2011 | EP2363115A2 Complexation of metal ions with polypeptides |
| 09/07/2011 | EP2362905A1 Screening method of anti-lung or esophageal cancer compounds |
| 09/07/2011 | EP2362904A1 Method for treating or preventing bladder cancer using the depdc1 polypeptide |
| 09/07/2011 | EP2362881A2 Crhr2 peptide agonists and uses thereof |
| 09/07/2011 | EP2362779A2 Cxcr4 receptor compounds |
| 09/07/2011 | EP2249869B1 Liquid formulation of fsh |
| 09/07/2011 | EP1807107B1 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
| 09/07/2011 | CN1761403B Method and compositions for improving animal health |
| 09/07/2011 | CN1526072B Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 09/07/2011 | CN102177176A Oxidant resistant apolipoprotein A-1 and mimetic peptides |
| 09/07/2011 | CN102176918A Treating or preventing gout |
| 09/07/2011 | CN102176900A Pharmaceutical compositions and related methods of delivery |
| 09/07/2011 | CN102176835A High caloric enteral formulations |
| 09/07/2011 | CN102175682A Bioactivity detection method and application of recombined humanized neuroglobin |
| 09/07/2011 | CN102174623A Fermentation method and application of yeast engineering bacteria |
| 09/07/2011 | CN102174533A Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 09/07/2011 | CN102174518A Main cis-acting element of shrimp white spot syndrome virus (WSSV) iel promoter and transcription factor combined with same and application |
| 09/07/2011 | CN102174478A Photosensitizer binding protein/polypeptide and application thereof to photodynamic gene therapy |
| 09/07/2011 | CN102174111A Human interleukin-2 (IL-2)/Fc fusion protein |
| 09/07/2011 | CN102174102A Stable analogs of peptide and polypeptide therapeutics |
| 09/07/2011 | CN102174097A Actinoporin and application thereof |
| 09/07/2011 | CN102174095A Malania oleifera lectin and method for preparing same |
| 09/07/2011 | CN102174084A Cyclic peptide analogues with thymosin alpha1 activity fragments and polyethylene glycol derivatives thereof |
| 09/07/2011 | CN102174083A Compositae cyclopeptide, immunosuppressive medicine using compositae cyclopeptide as active ingredient and preparation method and application of compositae cyclopeptide |
| 09/07/2011 | CN102174076A Compounds for proteasome enzyme inhibition |
| 09/07/2011 | CN102174075A Lipopeptide compound as well as compositions, preparation method and application thereof |
| 09/07/2011 | CN102174074A Inhabitors of cancer cell, T-cell and keratinocyte proliferation |
| 09/07/2011 | CN102172406A Intact minicells as vectors for DNA transfer and gene therapy in vitro and in vivo |
| 09/07/2011 | CN102172396A Application of protein factor Dmrt1 in regulating and controlling cell apoptosis |
| 09/07/2011 | CN102172395A Compositions and methods for treatment of microbial disorders |
| 09/07/2011 | CN102172394A Application of ciona intestinalis linnaeus peptides |
| 09/07/2011 | CN102172393A Calcium supplement of fish scale protein peptide calcium chelate and preparation method thereof |
| 09/07/2011 | CN102172345A Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight |
| 09/07/2011 | CN102172262A Enzyme treatment for infection |
| 09/07/2011 | CN101912424B Preparation method of red yeast rice containing Bacillus natto |